Edition:
United Kingdom

China Resources Pharmaceutical Group Ltd (3320.HK)

3320.HK on Hong Kong Stock

11.20HKD
19 Jul 2018
Change (% chg)

HK$-0.08 (-0.71%)
Prev Close
HK$11.28
Open
HK$11.28
Day's High
HK$11.28
Day's Low
HK$11.10
Volume
2,221,753
Avg. Vol
5,870,676
52-wk High
HK$12.80
52-wk Low
HK$9.02

Summary

Name Age Since Current Position

Yuning Fu

60 2016 Non-Executive Chairman of the Board

Qing Song

51 2017 President, Executive Director

Chuncheng Wang

54 2017 Chief Executive Officer, Executive Director

Guohui Li

45 2016 Chief Financial Officer, Vice President, Executive Director

Xin Li

60 2005 President of CR Double-Crane

Yufeng Qin

59 2011 President of Dong-E-E-Jiao

Hong Chen

57 2013 Senior Vice President

Yi Feng

55 2015 Senior Vice President

Jun Wu

55 2013 Senior Vice President

Ming Fang

58 2007 Vice President

Xiangming Li

52 2016 Standing Vice President and General Manager of CR Pharmaceutical Commercial

Qingsheng MENG

48 2016 Vice President

Huijun Yin

45 2014 Vice President

Song Jin

41 2016 Assistant President

Na Tang

40 2014 Chief Legal Advisor

Bing Zhao

44 2016 Assistant President of our Company and the Chairman of China Resources Zizhu Pharmaceutical Co., Ltd.

Chi Lik Lo

68 2016 Company Secretary

Rong Chen

44 2016 Non-Executive Director

Ruizhi Lu

45 2018 Non-Executive Director

Shouye Wang

47 2018 Non-Executive Director

Zhongliang Yu

52 2016 Non-Executive Director

Tingmei Fu

50 2016 Non-Executive Independent Director

Kin Fun Kwok

67 2016 Non-Executive Independent Director

Mo Han Shing

62 2017 Non-Executive Independent Director

Kejian Zhang

60 2016 Non-Executive Independent Director

Biographies

Name Description

Yuning Fu

Mr. Fu Yuning serves as Non-Executive Chairman of the Board of the Company. He was appointed as the chairman of the Board and a Director in December 2014 and designated as a non-executive Director in June 2016. Mr. FU also serves as the chairman of CR Holdings, a member of the 12th session of the Chinese People’s Political Consultative Conference, a member and vice chairman of APEC China Business Council, the honorary chairman of the Hong Kong Chinese Enterprises Association and a member of the General Committee of the Hong Kong General Chamber of Commerce. He served as the chairman of China Merchants Port Holdings Company Limited (formerly known as China Merchants Holdings (International) Company Limited), a company listed on the Stock Exchange (stock code: 0144), an independent non-executive director of CapitaLand Limited, a company listed on the Singapore Exchange Limited (stock code: C31), the chairman of China Merchants Group Limited, the chairman of China Merchants Bank Co., Ltd., a company listed on the Shanghai Stock Exchange (stock code: 600036) and the Stock Exchange (stock code: 03968) and an independent non-executive director of Li & Fung Limited, a company listed on the Stock Exchange (stock code: 0494). Mr. FU holds a doctorate degree from Brunel University in the United Kingdom.

Qing Song

Mr. Song Qing serves as President, Executive Director of the Company. He was appointed as a director of the Company in May 2016 and designated as an executive director of the Company in June 2016. Mr. SONG also currently serves as the chairman and a director of China Resources Sanjiu Medical & Pharmaceutical Company Limited(“CR Sanjiu”). Mr. SONG has over 30 years of experience in the pharmaceutical industry and corporate management. He served as an inspection pharmacist of quality inspection department, a pharmacist in charge and the director of production department, the director of the enterprise management department and an assistant to president of Shenzhen South Pharmaceutical Factory (the predecessor of CR Sanjiu), the general manager and chairman of Shanxi Sanjiu Tongda Pharmaceutical Company Limited(currently known as Shanxi Tongda Pharmaceutical Company Limited). Mr. SONG served as an assistant to general manager, the director of technology center, the director of medical & pharmaceutical department of Sanjiu Enterprise. Mr. SONG obtained his chief pharmacist title from the general logistics department of the People’s Liberation Army in April 1996. Mr. SONG holds a bachelor’s degree in Chinese medicine from Anhui University of Traditional Chinese Medicine in Hefei, the PRC.

Chuncheng Wang

Mr. Wang Chuncheng serves as Chief Executive Officer, Executive Director of the Company. He was appointed as a Director in December 2014, designated as an executive Director in June 2016 and appointed as the chief executive officer and the president in June 2016. Mr. WANG also serves as an assistant general manager of CR Holdings, the chairman of CR Pharmaceutical Holdings Company Limited, the chairman of CR Pharmaceutical Commercial, the chairman of CR Sanjiu, the chairman of CR Double-Crane, the chairman of Dong-E-E-Jiao, a vice chairman of Chinese Pharmaceutical Enterprises Association, and a director of the board of the International Federation of Pharmaceutical Wholesalers (IFPW). Mr. WANG has over 20 years of experience in corporate management. He served as a deputy director of the department of human resources of the Ministry of Foreign Trade and Economic Cooperation (currently known as Ministry of Commerce), a general manager of the human resources department and an assistant general manager of China Resources National Corporation, a general manager of the standing board office of CR Holdings, the chairman of Teck Soon Hong Limited, and the chairman of China Resources Textiles Holdings Co Ltd. Mr. WANG holds a bachelor’s degree in economics from Jilin Institute of Finance and Trade (currently known as Jilin University of Finance and Economics) in Changchun, the PRC.

Guohui Li

Mr. Li Guohui serves as Chief Financial Officer, Vice President, Executive Director of the Company. He was appointed as a Director in March 2016 and designated as an executive Director in June 2016. Mr. LI also serves as the chief financial officer and vice president of our Company, a director of CR Double- Crane, a director of Dong-E-E-Jiao and a supervisor of CR Sanjiu. Mr. LI has over 10 years of experience in financial and business analysis and financial management. Mr. LI joined CR Holdings in 2009 and served as the chief accounting officer of the finance department from September 2011. Mr. LI obtained a bachelor’s degree in shipbuilding techniques and equipment from the Faculty of Naval Architecture and Ocean Engineering of Wuhan Institute of Water Transportation Engineering (currently known as Wuhan University of Technology) in Wuhan, the PRC. He holds a master’s degree in business administration from Wuhan University, the PRC and a master’s degree in financial management from Nanyang Technological University in Singapore. Mr. LI is a CFA charter holder and a certified accountant of the Institute of Certified Public Accountant of Singapore.

Xin Li

Mr. Li Xin serves President of CR Double-Crane of the Company. He is was appointed as the president of Beijing Double-Crane Pharmaceutical Co., Ltd. (currently known as CR Double-Crane) in January 2005. Currently, Mr. LI also serves as a director of CR Double-Crane, an executive director of Beijing Double-Crane Pharmaceutical Business Co., Ltd. and the chairman of the board of directors of Beijing Double-Crane Pharmaceutical Marketing Co., Ltd.. Mr. LI has served as a deputy factory manager of Shenyang No.1 Pharmaceutical Factory (currently known as Northeast Pharmaceutical Group Shenyang No.1 Pharmaceutical Co., Ltd.), a deputy general manager of Northeast Pharmaceutical Group Co., Ltd., (a company listed on the Shenzhen Stock Exchange, stock code: 000597) and a standing deputy general manager of Beijing Pharmaceutical. Mr. LI was awarded a special government allowance by the State Council. Mr. LI obtained the qualification of a researcher-level senior engineer and a bachelor of science degree in antibiotics production from Shenyang Pharmaceutical College (currently known as Shenyang Pharmaceutical University) in Shenyang, the PRC.

Yufeng Qin

Mr. Qin Yufeng serves as President of Dong-E-E-Jiao of the Company. Mr. Qin was appointed as the president of Dong-E-E-Jiao in September 2011. Currently, Mr. QIN also serves as a director of Dong-E-E-Jiao, an MBA practice tutor of Communication University of China and a guest professor of Nanjing University of Chinese Medicine. Mr. QIN has served as an assistant to the factory manager in Shandong Dong-E-E-Jiao Factory (currently known as Dong-E-E-Jiao) and a standing vice president of Shandong Dong-E-EJiao Co., Ltd. (currently known as Dong-E-E-Jiao). Mr. QIN has four national patents. Mr. QIN was awarded a Special government allowances of the State Council. He was awarded titles of “Representative Inheritors of Dong’e Donkey-Hide Gelatin’s Production Techniques, a National Intangible Cultural Heritage National Outstanding Entrepreneur”, “2015 China Outstanding Quality People”, “Model Worker in Shandong Province” and “Top Ten Outstanding Engineers in Shandong Province”. He was also awarded prizes like the First Class Prize for Progress of Science and Technology of Shandong Province and “National May Day Labor Medal” Mr. QIN obtained the qualification of engineering technology application researcher in China and he obtained an EMBA degree from China Europe International Business School in Shanghai, the PRC.

Hong Chen

Mr. Chen Hong serves as Senior Vice President of the Company. Mr. Chen was appointed as a senior vice president of our Company in December 2013. Mr. CHEN has been a deputy factory manager of Beijing Second Pharmaceutical Factory currently known as China Resources Saike Pharmaceutical Co., Ltd., the chairman of Beijing Saike Pharmaceutical Co., Ltd., currently known as China Resources Saike Pharmaceutical Co., Ltd., a vice general manager of Beijing Pharmaceutical Co., Ltd. and the vice president of our Company. Mr. CHEN was awarded prizes like “Capital May Day Labor Medal Model Workers in Beijing” and “National May Day Labor Medal Mr. CHEN obtained the qualification of assistant engineer in China and he attended undergraduate class majoring in economic management in the Party School of Beijing Municipal Committee of the CPC

Yi Feng

Mr. Feng Yi serves as Senior Vice President of the Company. Mr. Feng was appointed as a senior vice president of our Company in December 2015. Currently, Mr. FENG also serves as a supervisor of Dong-E-E-Jiao. Mr. FENG has served as a deputy division researcher of the fifth division of the organization bureau, the division chief of the second division of training center of the organization department of the central committee of the CPC. He acted as a deputy general manager of human resource department of CR Holdings and served as a deputy general manager of China Resources Snow Breweries (Panjin) Co., Ltd. Mr. FENG has acted as a deputy general manager of China Resources Land (Beijing) Co., Ltd. the chief human resources officer and senior vice president of China Resources Bank of Zhuhai Co., Ltd. Mr. FENG obtained an EMBA degree from Peking University in Beijing, the PRC.

Jun Wu

Mr. Wu Jun serves as Senior Vice President of the Company. Mr. Wu was appointed as a senior vice president of our Company in December 2013. Currently, Mr. WU also serves as a director of CR Sanjiu, a director of Dong-E-E-Jiao, a supervisor of CR Double-Crane, a vice president of China Nonprescription Medicines Association. Mr. WU has been a director and the general manager of China Resources Machinery and Minmetals (Holdings) Co., Ltd. a deputy general manager in the enterprise development department of CR Holdings, a director and deputy general manager of CR Investment & Development Company Limited a deputy general manager in the internal audit department of CR Holdings and a vice president of our Company. Mr. WU obtained the qualification of senior engineer in China and he obtained an MBA degree from University of San Francisco in San Francisco, the United States of America.

Ming Fang

Mr. Fang Ming serves as Vice President of the Company. Mr. Fang was appointed as a vice president of our Company in December 2007. Currently, Mr. FANG also serves as a supervisor of CR Double-Crane, a supervisor of CR Sanjiu and a supervisor of Dong-E-E-Jiao. Mr. FANG was an associate researcher at the Institute of Social China Academy of Social Sciences. Mr. FANG has served as a senior manager of the research department of CR Holdings, a deputy general manager of the enterprise development department of CR Holdings, a director and the deputy general manager of China Resources Development & Investment Company Limited, the executive manager in charge of listing planning of CRNC, a member of the management board and the general manager of capital operation department of CRNC. Mr. FANG obtained a doctor of law degree in applied sociology from the Graduate School of Chinese Academy of Social Sciences in Beijing, the PRC.

Xiangming Li

Mr. Li Xiangming serves as Standing Vice President and General Manager of CR Pharmaceutical Commercial of the Company. Currently. He was appointed as a standing vice president of our Company in January 2016. Currently, Mr. LI also holds various positions in our Group, including the general manager of CR Pharmaceutical Commercial, the chairman of China Resources Henan Pharmaceutical Co., Ltd. the chairman of CR Shandong Pharmaceutical Co., Ltd., the chairman of CR Guangdong Pharmaceutical Co., Ltd. etc., a vice president of China Association of Pharmaceutical Commerce, a vice president of Beijing Logistics Association, a member of Beijing Pharmaceutical Association and a vice president of China National Narcotic Drugs Association. Mr. LI has been a deputy general manager of Beijing Pharmaceutical Economic and Technological Management Company, the general manager of Beijing Pharmaceutical Co., Ltd. (currently known as CR Pharmaceutical Commercial), the president of CR Pharmaceutical Commercial and the senior vice president of our Company. Mr. LI is a traditional Chinese pharmacist. He obtained an EMBA degree from University of International Business and Economics in Beijing, the PRC.

Qingsheng MENG

Mr. MENG Qingsheng is Vice President of the company. He was appointed as a vice president of our Company in October 2016. Mr. MENG has engaged in the Information Technology (IT) consultancy and management business for over 20 years. Mr. MENG has extensive experience in areas like corporate IT strategic planning, system structural design, project management and the training of professional personnel. Mr. MENG successively held positions in SSA China Co., Ltd., Platinum China Co., Ltd. and Oracle China Co., Ltd.. Mr. MENG has also acted as a deputy director of the Information Management Department of CR Holdings.

Huijun Yin

Mr. Yin Huijun serves as Vice President of the Company. Mr. Yin also serves as the chairman of Pharmaceutical R&D Center, a deputy secretary-general of Medical and Health sector of All-China Youth Federation, a council member of China Association of Youth Science and Technology, a standing member of Special Committee on Cardiovascular under Doctor Society of Integrative Medicine, a Ph.D. tutor of China Academy of Chinese Medical Sciences, and a graduate student tutor of Gansu University of Chinese Medicine. He served as the cardiovascular laboratory director of Xiyuan Hospital under China Academy of Chinese Medical Sciences (the former China Academy of Traditional Chinese Medicine) from September 2004 to December 2010, a standing director of Specialty Committee of Cardiovascular Diseases of World Federation of Chinese Medicine Societies from September 2010 to September 2014, a vice president of Affiliated Hospital of Gansu University of Chinese Medicine from December 2010 to November 2011, and served in Xiyuan Hospital under China Academy of Chinese Medical Sciences from November 2011 to June 2013. He served as the chief of international cooperation department of China Academy of Chinese Medical Sciences from June 2013 to May 2014. Mr. Yin was awarded the “Star of Science and Technology” by TCM Society in February 2011, the Second Class Prize for Progress of Science and Technology of Beijing by the People’s Government of Beijing Municipality in January 2014, “Flying Apsaras Scholar” guest professor employed by Gansu University of Chinese Medicine in December 2014 and the Second Class Prize for Progress of National Science and Technology by the State Council in December 2015. Mr. Yin obtained the qualification of researcher issued by China Academy of Chinese Medical Sciences in December 2006. Mr. Yin obtained a bachelor’s degree in traditional Chinese medicine from Ningxia Medical College (currently known as Ningxia Medical University) in Yinchuan.

Song Jin

Mr. Jin Song serves as Assistant President of the Company. Mr. Jin successively served as a staff member, a principal staff member, a senior staff member, a deputy division-level consultant and a division-level consultant at the SFDA (currently known as the CFDA) from August 1999 to May 2016. Mr. Jin obtained a bachelor of engineering degree in pharmaceutical preparations from the School of Pharmacy of China Pharmaceutical University in Nanjing, the PRC in July 1998, and obtained a master’s degree in international cooperation policy from the public health management department of Ritsumeikan University in Kyoto, Japan in September 2010.

Na Tang

Ms. Tang Na serves as Chief Legal Advisor of the Company. Ms. Tang was appointed as the chief legal advisor of our Company in March 2014. Ms. TANG served as a partner of Concord & Partners and a director of legal affairs of CR Pharmaceutical Commercial. Ms. TANG obtained the qualification of PRC lawyer and the corporate counsel qualification. Ms. TANG obtained a bachelor of law degree from China University of Political Science and Law in Beijing, the PRC and attended postgraduate courses majoring in urban economics in the School of Economics at Renmin University of China in Beijing, the PRC.

Bing Zhao

Mr. ZHAO Bingxiang is appointed as an assistant president of our Company and the chairman of China Resources Zizhu Pharmaceutical Co., Ltd. in September 2016. Mr. ZHAO has served as a marketing officer of San-jiu Pharmaceutical trade Co., Ltd., a deputy general manager of San-jiu Tongda Pharmaceutical Co., Ltd., a senior researcher of the R&D center and the general manager of the Profit Center of CR Sanjiu. Mr. ZHAO obtained a master of Pharmaceutics degree from Peking University in Beijing, the PRC.

Chi Lik Lo

Mr. Lo Chi Lik Peter serves as Company Secretary of the Company. Mr. Lo graduated from the University of Hong Kong and obtained the qualification of a solicitor in Hong Kong in 1976 and has been in continuous practice as a solicitor since then. Mr. Lo is currently a partner of Messrs. Woo, Kwan, Lee & Lo. Mr. Lo also serves as the company secretary of China Resources Land Limited (listed on Hong Kong Stock Exchange, stock code: 1109) and China Resources Cement Holdings Limited (listed on Hong Kong Stock Exchange, stock code: 1313).

Rong Chen

Mr. Chen Rong serves as Non-Executive Director of the Company. He was appointed as General Manager of the Finance Department of CR Holdings in February 2016. Mr. CHEN was appointed as non-executive director of China Resources Beer (Holdings) Company Limited (formerly known as China Resources Enterprise, Limited), a company listed on the Stock Exchange (stock code: 291) in April 2016 and a Director in May 2016 and designated as a non-executive Director in June 2016. Mr. CHEN has previously worked in Epson Technical Limited, Walmart China Investment Limited and Fuji Electric Technical Services Limited. Mr. CHEN joined CR Holdings in May 2007, he was the head of tax management of the Finance Department of CR Holdings and deputy general manager and chief financial officer of China Resources Vanguard Company Limited. Mr. CHEN holds MBA degree from Xi’an Jiaotong University. He is an Intermediate Accountant and a Certified Tax Agent in China. He is also a nonpracticing member of the Chinese Institute of Certified Public Accountants.

Ruizhi Lu

Mr. Lu Ruizhi is Non-Executive Director of the Company. He joined BSCOMC in 2010 and is currently the general manager of the investment management second division of BSCOMC. Mr. LU has many years of experience in investment management. He was the vice manager of the securities department of Beijing Capital Development Co., Ltd.and the vice general manager of the investment management division of BSCOMC. Mr. LU graduated from the department of investment economics of Renmin University of China in 1995 majoring in investment economics management and obtained a master’s degree in accounting from the School of Business of Renmin University of China in 2002. He is also an economist in the PRC.

Shouye Wang

Mr. Wang Shouye is Non-Executive Director of the Company. He joined BSCOMC in 2010 and is currently the chief financial officer of BSCOMC. He was a director of the Company from October 2011 to June 2016. Mr. WANG was also a non-executive director of CSC Financial Co., Ltd., a company listed on The Stock Exchange of Hong Kong Limited (stock code: 6066), from August 2016 to February 2018. Mr. WANG has over 10 years of experience in financial management. He was the director of finance and audit division of Beijing Coal Corporation, the director of finance and audit division, the director of finance and audit department, the director of finance department, and the director of finance and price department of Beijing Jintai Hengye Co., Ltd, a subsidiary of Beijing Jingmei Group Co. Ltd. and the director of finance department of Beijing Golden Tide Group Co. Ltd, a subsidiary of Beijing Jingmei Group Co. Ltd. Mr. WANG graduated from Fuxin Mining Institute majoring in statistics in 1992 and graduated from the School of Continuing Education of Renmin University of China on a part-time basis in 1997 majoring in investment and economics management. Mr. WANG obtained a master’s degree in business management and economics from Liaoning Technical University in 2006. He is also a senior accountant and senior statistician in the PRC.

Zhongliang Yu

Mr. Yu Zhongliang serves as Non-Executive Director of the Company. He was appointed as a non-executive Director in June 2016. Mr. YU also serves as a senior deputy general manager of the strategy management department of CR Holdings. Mr. YU has over 20 years of experience in investment, business analysis and strategic development. Mr. YU was successively the strategic development controller, an executive director and a vice chairman of China Resources Cement Holdings Limited, a company listed on the Stock Exchange (stock code: 1313). Mr. YU holds an MBA degree of York University in Toronto, Canada.

Tingmei Fu

Dr. Fu Tingmei Ph.D. serves as Non-Executive Independent Director of the Company. Mr. Fu was appointed as an independent non-executive Director in June 2016. Mr. FU has over 20 years of experience in investment, finance, law and business management. Mr. FU currently serves as an independent non-executive director of CPMC Holdings Limited, a company listed on the Stock Exchange (stock code: 0906), Beijing Enterprises Holdings Limited, a company listed on the Stock Exchange (stock code: 0392), Guotai Junan International Holdings Limited, a company listed on the Stock Exchange (stock code: 1788), Postal Savings Bank of China Co., Ltd., a company listed on the Stock Exchange (stock code: 1658) and COFCO Meat Holdings Limited, a company listed on the Stock Exchange (stock code: 1610). Mr. FU holds a master’s degree in law and a Ph.D. degree in law from London University, the United Kingdom.

Kin Fun Kwok

Mr. Kwok Kin Fun serves as Non-Executive Independent Director of the Company. Mr. Kwok was appointed as an independent non-executive Director in June 2016. Mr. KWOK also serves as an Executive Committee member of Rehabilitation International and global Vice Chairman of Social Commission of Rehabilitation International, the chairman of Incheon Strategy Group Committee of Asia and Pacific Disability Forum, a vice chairman of The Hong Kong Joint Council for People with Disabilities, a vice chairman of The Hong Kong Society for Rehabilitation, the chairman of Fu Hong Society, a member of Ethics Research Committee of Hospital Authority Kowloon Central and Kowloon East Clusters, a member of Voting Members Committee of Riding For the Disabled Association, the chairman of Accessible IT Development Association Limited. Mr. KWOK has over 30 years of experience in disability research and medical research ethics. He successively served as a senior lecturer, a principal lecturer, a university senior lecturer and an associate professor of the City University of Hong Kong from 1985 to 2009, and after retirement served as full-time and part-time senior research fellow. Mr. KWOK was appointed as a Justice of the Peace (JP) by the government of Hong Kong in 1997 and received the Bronze Bauhinia Star awarded by the government of Hong Kong SAR in 2005, “Kazuo Itoga” Memorial Prize awarded by the government of Shiga Prefecture, Japan in 2006, and the Promoter title of “Asian and Pacific Decade of Persons with Disabilities, 2013–2022” awarded by United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP) in 2012. Mr. KWOK holds a bachelor’s degree in social science from the University of Hong Kong, a master’s degree in social science from the Chinese University of Hong Kong, and a Ph.D. degree from the University of Nottingham, the UK.

Mo Han Shing

Ms. Shing Mo Han Yvonne is Non-Executive Independent Director of the Company. She was appointed as a Justice of Peace by the HKSAR Government in 2013 and awarded Bronze Bauhinia Star in 2017. Mdm. SHING is currently the chairman of Yinn Advisory Services Limited. Mdm. SHING was a partner of Deloitte China for over 26 years until her retirement in May 2016. She is also a member of the 10th and 11th Jiangsu Provincial Committee of the Chinese People’s Political Consultative Conference. She is a founding member and past president of the Association of Women Accountants (Hong Kong) and the past chairman of Hong Kong Institute of Certified Public Accountants Taxation Committee. She is now the vice-chairman of Hong Kong General Chamber of Commerce Tax Committee, council member of Association of Women Accountants (Hong Kong), and member of Chinese General Chamber of Commerce. Her professional qualifications include fellow member of the Hong Kong Institute of Certified Public Accountants, Association of Chartered Certified Accountants and Institute of Chartered Secretaries and Administrators. Her current public appointments include treasurer of the Council of the Hong Kong Academy for Performing Arts, member of the Corruption Prevention Advisory Committee of the Independent Commission Against Corruption, member of the Antiquities Advisory Board, member of the Communications Authority, member of the Advisory Committee on Built Heritage Conservation, court member of the Hong Kong Polytechnic University, and advisor and member of the Finance Committee of Our Hong Kong Foundation. She received the National Hundred Outstanding Women Entrepreneurs Award in Great Hall of the People in Beijing. She also received the Outstanding Alumni Award of Hong Kong Polytechnic University in 2007. Mdm. SHING has been consecutively named from 2001 to 2015 in International Tax Review as one of the World’s Leading Tax Advisors in Hong Kong and Mainland.

Kejian Zhang

Mr. Zhang Kejian serves as Non-Executive Independent Director of the Company. Mr. Zhang was appointed as an independent non-executive Director in June 2016. Mr. ZHANG also serves as an independent director of Yifan Pharmaceutical Co., Ltd. (a company listed on Shenzhen Stock Exchange, stock code: 002019), an independent director of CR Double-Crane and the Chief Scientist of The South China Center for Innovative Pharmaceuticals. Mr. ZHANG has over 20 years of experience in the pharmaceutical industry of PRC. He was employed as a professor of School of Pharmaceutical Sciences of Sun Yat-sen University and the director (Pharmacy Administration) of The South China Center for Innovative Pharmaceuticals, a researcher at the Institute of Medicine, Chinese Academy of Medical Sciences, and successively served as a deputy director of Pharmaceutical Evaluation Center and a deputy director of Medical Device Evaluation Center under the State Food and Drug Administration of the PRC. Mr. ZHANG received a master’s degree in pathophysiology from China Medical University in Shenyang, the PRC and a doctor’s degree in pharmacy from the School of Pharmaceutical Sciences of Chiba University in Chiba, Japan.